Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran-Reference-Cited by-同舟云学术

Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran

Published:2023-02 Issue: Volume:243 Page:109751
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Khezri Mehrdad,Mirzazadeh Ali,Shokoohi Mostafa,Sharafi Heidar,Ghalekhani Nima,Tavakoli Fatemeh,Mehmandoost Soheil,Mousavian Ghazal,Imani Mousa,Kakavand-Ghalehnoei Rezvan,Komasi Ali,Gouya Mohammad Mehdi,Haghdoost Ali Akbar,McFarland Willi,Karamouzian Mohammad,Sharifi Hamid

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference41 articles.

1. An Intervention to Improve HCV Testing, Linkage to Care, and Treatment among People Who Use Drugs in Tehran;Alavi,2019

2. Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review;Bajis;Int. J. Drug Policy,2017

3. Drug consumption rooms (DCRs) as a setting to address hepatitis C–findings from an international online survey;Belackova;Hepatol. Med Policy,2018

4. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs;Bruggmann;Int. J. Drug Policy,2015

5. Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all;Bruggmann;Clin. Infect. Dis.,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam study;Substance Abuse Treatment, Prevention, and Policy;2023-11-29